Advertisement

Ads Placeholder
Loading...

Ascendis Pharma A/S

ASND•NASDAQ
Healthcare
Biotechnology
$229.25
$1.010(0.44%)
U.S. Market opens in 25h 25m

Ascendis Pharma A/S (ASND) Stock Overview

Explore Ascendis Pharma A/S’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap14.1B
P/E Ratio-53.64
EPS (TTM)$-4.36
ROE1.28%
Fundamental Analysis

AI Price Forecasts

1 Month$223.83
3 Months$259.48
1 Year Target$187.08

ASND Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Ascendis Pharma A/S (ASND) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 53.80, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $187.08.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -53.64 and a market capitalization of 14.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.44%
5-Day Change
3.88%
1-Month Change
-4.17%
3-Month Change
7.48%
6-Month Change
12.35%
Year-to-Date (YTD) Change
7.48%
1-Year Change
52.74%
3-Year Change
214.77%
5-Year Change
74.07%
All-Time (Max) Change
1117.47%

Contact Information

https://ascendispharma.com
45 70 22 22 44
Tuborg Boulevard 12, Hellerup, NaN, 2900

Company Facts

10,170 Employees
IPO DateJan 28, 2015
CountryDK
Actively Trading

Frequently Asked Questions